CT technology shows how blood flow can predict effectiveness of ovarian cancer treatment

Technology can provide a new window into whether or not patients are responding to treatment for advanced ovarian cancer. A multi-center clinical trial has demonstrated that CT Perfusion, which measures blood flow and blood volume to tumors associated with ovarian cancer, can provide an accurate prediction of how well a treatment is working, allowing physicians the opportunity to better plan treatment.